{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:14Z","timestamp":1772119994354,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82202906"],"award-info":[{"award-number":["82202906"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-024-04116-4","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T05:15:04Z","timestamp":1732770904000},"page":"234-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting RACGAP1 suppresses growth hormone pituitary adenoma growth"],"prefix":"10.1007","volume":"88","author":[{"given":"Feifan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"issue":"3","key":"4116_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"S. Ezzat, S.L. Asa, W.T. Couldwell, C.E. Barr, W.E. Dodge, M.L. Vance, I.E. McCutcheon, The prevalence of pituitary adenomas: a systematic review. Cancer 101(3), 613\u2013619 (2004). https:\/\/doi.org\/10.1002\/cncr.20412","journal-title":"Cancer"},{"issue":"5","key":"4116_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4158\/EP-2018-0034","volume":"24","author":"CT Lim","year":"2018","unstructured":"C.T. Lim, M. Korbonits, Update on the Clinicopathology of Pituitary Adenomas. Endocr Pract 24(5), 473\u2013488 (2018). https:\/\/doi.org\/10.4158\/EP-2018-0034","journal-title":"Endocr Pract"},{"issue":"5","key":"4116_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"M.E. Molitch, Diagnosis and Treatment of Pituitary Adenomas: A Review. JAMA 317(5), 516\u2013524 (2017). https:\/\/doi.org\/10.1001\/jama.2016.19699","journal-title":"JAMA"},{"issue":"11","key":"4116_CR4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","volume":"10","author":"M Fleseriu","year":"2022","unstructured":"M. Fleseriu, F. Langlois, D. Lim, E.V. Varlamov, S. Melmed, Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol 10(11), 804\u2013826 (2022). https:\/\/doi.org\/10.1016\/S2213-8587(22)00244-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"4116_CR5","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"L. Katznelson, E.R. Laws Jr, S. Melmed, M.E. Molitch, M.H. Murad, A. Utz, J.A. Wass,Endocrine Society Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11), 3933\u20133951 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4116_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"A. Giustina, G. Barkhoudarian, A. Beckers, A. Ben-Shlomo, N. Biermasz, B. Biller, C. Boguszewski, M. Bolanowski, J. Bollerslev, V. Bonert, M.D. Bronstein, M. Buchfelder, F. Casanueva, P. Chanson, D. Clemmons, M. Fleseriu, A.M. Formenti, P. Freda, M. Gadelha, E. Geer, M. Gurnell, A.P. Heaney, K. Ho, A.G. Ioachimescu, S. Lamberts, E. Laws, M. Losa, P. Maffei, A. Mamelak, M. Mercado, M. Molitch, P. Mortini, A.M. Pereira, S. Petersenn, K. Post, M. Puig-Domingo, R. Salvatori, S.L. Samson, I. Shimon, C. Strasburger, B. Swearingen, P. Trainer, M.L. Vance, J. Wass, M.E. Wierman, K. Yuen, M.C. Zatelli, S. Melmed, Multidisciplinary management of acromegaly: A consensus. Rev Endocr Metab Disord 21(4), 667\u2013678 (2020). https:\/\/doi.org\/10.1007\/s11154-020-09588-z","journal-title":"Rev Endocr Metab Disord"},{"issue":"9","key":"4116_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"S. Melmed, M.D. Bronstein, P. Chanson, A. Klibanski, F.F. Casanueva, J. Wass, C.J. Strasburger, A. Luger, D.R. Clemmons, A. Giustina, A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9), 552\u2013561 (2018). https:\/\/doi.org\/10.1038\/s41574-018-0058-5","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"4116_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-023-01360-1","volume":"27","author":"A Giustina","year":"2024","unstructured":"A. Giustina, N. Biermasz, F.F. Casanueva, M. Fleseriu, P. Mortini, C. Strasburger, A.J. van der Lely, J. Wass, S. Melmed, G. Acromegaly Consensus, Consensus on criteria for acromegaly diagnosis and remission. Pituitary 27(1), 7\u201322 (2024). https:\/\/doi.org\/10.1007\/s11102-023-01360-1","journal-title":"Pituitary"},{"issue":"1","key":"4116_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","volume":"5","author":"A Colao","year":"2019","unstructured":"A. Colao, L. Grasso, A. Giustina, S. Melmed, P. Chanson, A.M. Pereira, R. Pivonello, Acromegaly. Nat Rev Dis Primers 5(1), 20 (2019). https:\/\/doi.org\/10.1038\/s41572-019-0071-6","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"4116_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/neuros\/nyx020","volume":"81","author":"H Babu","year":"2017","unstructured":"H. Babu, A. Ortega, M. Nuno, A. Dehghan, A. Schweitzer, H.V. Bonert, J.D. Carmichael, O. Cooper, S. Melmed, A.N. Mamelak, Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors. Neurosurgery 81(2), 357\u2013366 (2017). https:\/\/doi.org\/10.1093\/neuros\/nyx020","journal-title":"Neurosurgery"},{"key":"4116_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.wneu.2017.04.141","volume":"104","author":"JH Kim","year":"2017","unstructured":"J.H. Kim, K.Y. Hur, J.H. Lee, J.H. Lee, Y.B. Se, H.I. Kim, S.H. Lee, D.H. Nam, S.Y. Kim, K.W. Kim, D.S. Kong, Y.H. Kim, Outcome of Endoscopic Transsphenoidal Surgery for Acromegaly. World Neurosurg 104, 272\u2013278 (2017). https:\/\/doi.org\/10.1016\/j.wneu.2017.04.141","journal-title":"World Neurosurg"},{"issue":"11","key":"4116_CR12","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00701-017-3318-6","volume":"159","author":"CJ Chen","year":"2017","unstructured":"C.J. Chen, N. Ironside, I.J. Pomeraniec, S. Chivukula, T.J. Buell, D. Ding, D.G. Taylor, R.F. Dallapiazza, C.C. Lee, M. Bergsneider, Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications. Acta Neurochir (Wien) 159(11), 2193\u20132207 (2017). https:\/\/doi.org\/10.1007\/s00701-017-3318-6","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"4116_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/14728214.2020.1819983","volume":"25","author":"C Campana","year":"2020","unstructured":"C. Campana, G. Corica, F. Nista, F. Cocchiara, G. Graziani, K. Khorrami, M. Franco, M. Boschetti, D. Ferone, F. Gatto, Emerging drugs for the treatment of acromegaly. Expert Opin Emerg Drugs 25(4), 409\u2013417 (2020). https:\/\/doi.org\/10.1080\/14728214.2020.1819983","journal-title":"Expert Opin Emerg Drugs"},{"issue":"2","key":"4116_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1210\/er.2010-0002","volume":"32","author":"A Colao","year":"2011","unstructured":"A. Colao, R.S. Auriemma, G. Lombardi, R. Pivonello, Resistance to somatostatin analogs in acromegaly. Endocr Rev 32(2), 247\u2013271 (2011). https:\/\/doi.org\/10.1210\/er.2010-0002","journal-title":"Endocr Rev"},{"issue":"10","key":"4116_CR15","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1210\/jc.2014-2032","volume":"99","author":"SJ Neggers","year":"2014","unstructured":"S.J. Neggers, S.E. Franck, F.W. de Rooij, A.H. Dallenga, R.M. Poublon, R.A. Feelders, J.A. Janssen, M. Buchfelder, L.J. Hofland, J.O. J\u00f8rgensen, A.J. van der Lely, Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly. J Clin Endocrinol Metab 99(10), 3644\u20133652 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2032","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"4116_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/cen.12207","volume":"79","author":"TA Howlett","year":"2013","unstructured":"T.A. Howlett, D. Willis, G. Walker, J.A. Wass, P.J. Trainer; UK Acromegaly Register Study Group (UKAR-3), Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists. Clin Endocrinol (Oxf) 79(5), 689\u2013699 (2013). https:\/\/doi.org\/10.1111\/cen.12207","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"4116_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11102-016-0778-2","volume":"20","author":"A Ben-Shlomo","year":"2017","unstructured":"A. Ben-Shlomo, N.A. Liu, S. Melmed, Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas. Pituitary 20(1), 93\u201399 (2017). https:\/\/doi.org\/10.1007\/s11102-016-0778-2","journal-title":"Pituitary"},{"key":"4116_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fendo.2015.00187","volume":"6","author":"E Peverelli","year":"2015","unstructured":"E. Peverelli, D. Treppiedi, E. Giardino, E. Vitali, A.G. Lania, G. Mantovani, Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement. Front Endocrinol (Lausanne) 6, 187 (2015). https:\/\/doi.org\/10.3389\/fendo.2015.00187","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"4116_CR19","doi-asserted-by":"publisher","first-page":"958","DOI":"10.2176\/nmc.ra.2014-0239","volume":"54","author":"Y Oki","year":"2014","unstructured":"Y. Oki, Medical management of functioning pituitary adenoma: an update. Neurol Med Chir (Tokyo) 54(12), 958\u2013965 (2014). https:\/\/doi.org\/10.2176\/nmc.ra.2014-0239","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"4116_CR20","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/neuros\/nyaa054","volume":"87","author":"CS Graffeo","year":"2020","unstructured":"C.S. Graffeo, D. Donegan, D. Erickson, P.D. Brown, A. Perry, M.J. Link, W.F. Young, B.E. Pollock, The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study. Neurosurgery 87(3), 538\u2013546 (2020). https:\/\/doi.org\/10.1093\/neuros\/nyaa054","journal-title":"Neurosurgery"},{"issue":"3","key":"4116_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0360-3016(98)00256-9","volume":"42","author":"M Mitsumori","year":"1998","unstructured":"M. Mitsumori, D.C. Shrieve, E. Alexander, U.B. Kaiser, G.E. Richardson, P.M. Black, J.S. Loeffler, Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 42(3), 573\u2013580 (1998). https:\/\/doi.org\/10.1016\/s0360-3016(98)00256-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"4116_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/35106065","volume":"1","author":"M Malumbres","year":"2001","unstructured":"M. Malumbres, M. Barbacid, To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1(3), 222\u2013231 (2001). https:\/\/doi.org\/10.1038\/35106065","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4116_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1677\/JME-08-0146","volume":"42","author":"V Quereda","year":"2009","unstructured":"V. Quereda, M. Malumbres, Cell cycle control of pituitary development and disease. J Mol Endocrinol 42(2), 75\u201386 (2009). https:\/\/doi.org\/10.1677\/JME-08-0146","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"4116_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12022-021-09663-4","volume":"32","author":"SL Asa","year":"2021","unstructured":"S.L. Asa, O. Mete, S. Ezzat, Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know? Endocr Pathol 32(1), 3\u201316 (2021). https:\/\/doi.org\/10.1007\/s12022-021-09663-4","journal-title":"Endocr Pathol"},{"issue":"2","key":"4116_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4161\/sgtp.23708","volume":"4","author":"R Cs\u00e9p\u00e1nyi-K\u00f6mi","year":"2013","unstructured":"R. Cs\u00e9p\u00e1nyi-K\u00f6mi, D. S\u00e1f\u00e1r, V. Gr\u00f3sz, Z.L. Tarj\u00e1n, E. Ligeti, In silico tissue-distribution of human Rho family GTPase activating proteins. Small GTPases 4(2), 90\u2013101 (2013). https:\/\/doi.org\/10.4161\/sgtp.23708","journal-title":"Small GTPases"},{"issue":"11","key":"4116_CR26","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1074\/jbc.273.11.6019","volume":"273","author":"A Tour\u00e9","year":"1998","unstructured":"A. Tour\u00e9, O. Dorseuil, L. Morin, P. Timmons, B. J\u00e9gou, L. Reibel, G. Gacon, MgcRacGAP, a new human GTPase-activating protein for Rac and Cdc42 similar to Drosophila rotundRacGAP gene product, is expressed in male germ cells. J Biol Chem 273(11), 6019\u20136023 (1998). https:\/\/doi.org\/10.1074\/jbc.273.11.6019","journal-title":"J Biol Chem"},{"key":"4116_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","volume":"21","author":"AB Jaffe","year":"2005","unstructured":"A.B. Jaffe, A. Hall, Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21, 247\u2013269 (2005). https:\/\/doi.org\/10.1146\/annurev.cellbio.21.020604.150721","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"17","key":"4116_CR28","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1016\/j.yexcr.2007.07.022","volume":"313","author":"P Aspenstrom","year":"2007","unstructured":"P. Aspenstrom, A. Ruusala, D. Pacholsky, Taking Rho GTPases to the next level: the cellular functions of atypical Rho GTPases. Exp Cell Res 313(17), 3673\u20133679 (2007). https:\/\/doi.org\/10.1016\/j.yexcr.2007.07.022","journal-title":"Exp Cell Res"},{"issue":"1","key":"4116_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1091\/mbc.e05-06-0569","volume":"17","author":"K Kamijo","year":"2006","unstructured":"K. Kamijo, N. Ohara, M. Abe, T. Uchimura, H. Hosoya, J.S. Lee, T. Miki, Dissecting the role of Rho-mediated signaling in contractile ring formation. Mol Biol Cell 17(1), 43\u201355 (2006). https:\/\/doi.org\/10.1091\/mbc.e05-06-0569","journal-title":"Mol Biol Cell"},{"issue":"8","key":"4116_CR30","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1074\/jbc.M007252200","volume":"276","author":"K Hirose","year":"2001","unstructured":"K. Hirose, T. Kawashima, I. Iwamoto, T. Nosaka, T. Kitamura, MgcRacGAP is involved in cytokinesis through associating with mitotic spindle and midbody. J Biol Chem 276(8), 5821\u20135828 (2001). https:\/\/doi.org\/10.1074\/jbc.M007252200","journal-title":"J Biol Chem"},{"issue":"13","key":"4116_CR31","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/onc.2009.2","volume":"28","author":"D Yamazaki","year":"2009","unstructured":"D. Yamazaki, S. Kurisu, T. Takenawa, Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene 28(13), 1570\u20131583 (2009). https:\/\/doi.org\/10.1038\/onc.2009.2","journal-title":"Oncogene"},{"issue":"1","key":"4116_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10120-014-0355-1","volume":"18","author":"S Saigusa","year":"2015","unstructured":"S. Saigusa, K. Tanaka, Y. Mohri, M. Ohi, T. Shimura, T. Kitajima, S. Kondo, Y. Okugawa, Y. Toiyama, Y. Inoue, M. Kusunoki, Clinical significance of RacGAP1 expression at the invasive front of gastric cancer. Gastric Cancer 18(1), 84\u201392 (2015). https:\/\/doi.org\/10.1007\/s10120-014-0355-1","journal-title":"Gastric Cancer"},{"issue":"7","key":"4116_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05036-9","volume":"13","author":"T Zhang","year":"2022","unstructured":"T. Zhang, C. Wang, K. Wang, Y. Liang, T. Liu, L. Feng, X. Yang, RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK. Cell Death Dis 13(7), 604 (2022). https:\/\/doi.org\/10.1038\/s41419-022-05036-9","journal-title":"Cell Death Dis"},{"issue":"2","key":"4116_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11060-013-1121-7","volume":"113","author":"HL Ke","year":"2013","unstructured":"H.L. Ke, R.H. Ke, S.T. Li, B. Li, H.T. Lu, X.Q. Wang, Expression of RACGAP1 in high grade meningiomas: a potential role in cancer progression. J Neurooncol 113(2), 327\u2013332 (2013). https:\/\/doi.org\/10.1007\/s11060-013-1121-7","journal-title":"J Neurooncol"},{"issue":"2","key":"4116_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10142-019-00706-y","volume":"20","author":"T Chen","year":"2020","unstructured":"T. Chen, S. Yang, J. Xu, W. Lu, X. Xie, Transcriptome sequencing profiles of cervical cancer tissues and SiHa cells. Funct Integr Genomics 20(2), 211\u2013221 (2020). https:\/\/doi.org\/10.1007\/s10142-019-00706-y","journal-title":"Funct Integr Genomics"},{"issue":"18","key":"4116_CR36","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1158\/1078-0432.CCR-11-0557","volume":"17","author":"SM Wang","year":"2011","unstructured":"S.M. Wang, L.L. Ooi, K.M. Hui, Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin Cancer Res 17(18), 6040\u20136051 (2011). https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0557","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4116_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76555-8","volume":"10","author":"K Taniguchi-Ponciano","year":"2020","unstructured":"K. Taniguchi-Ponciano, S. Andonegui-Elguera, E. Pe\u00f1a-Mart\u00ednez, G. Silva-Rom\u00e1n, S. Vela-Pati\u00f1o, E. Gomez-Apo, L. Chavez-Macias, G. Vargas-Ortega, L. Espinosa-de-Los-Monteros, B. Gonzalez-Virla, C. Perez, A. Ferreira-Hermosillo, E. Espinosa-Cardenas, C. Ramirez-Renteria, E. Sosa, B. Lopez-Felix, G. Guinto, D. Marrero-Rodr\u00edguez, M. Mercado, Transcriptome and methylome analysis reveals three cellular origins of pituitary tumors. Sci Rep 10(1), 19373 (2020). https:\/\/doi.org\/10.1038\/s41598-020-76555-8","journal-title":"Sci Rep"},{"issue":"9","key":"4116_CR38","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jid.2019.03.1136","volume":"139","author":"CC Deng","year":"2019","unstructured":"C.C. Deng, D.H. Zhu, Y.J. Chen, T.Y. Huang, Y. Peng, S.Y. Liu, P. Lu, Y.H. Xue, Y.P. Xu, B. Yang, Z. Rong, TRAF4 Promotes Fibroblast Proliferation in Keloids by Destabilizing p53 via Interacting with the Deubiquitinase USP10. J Invest Dermatol 139(9), 1925\u20131935 e5 (2019). https:\/\/doi.org\/10.1016\/j.jid.2019.03.1136","journal-title":"J Invest Dermatol"},{"issue":"8","key":"4116_CR39","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.febslet.2007.12.036","volume":"582","author":"A Tour\u00e9","year":"2008","unstructured":"A. Tour\u00e9, R. Mzali, C. Liot, L. Seguin, L. Morin, C. Crouin, I. Chen-Yang, Y.G. Tsay, O. Dorseuil, G. Gacon, J. Bertoglio, Phosphoregulation of MgcRacGAP in mitosis involves Aurora B and Cdk1 protein kinases and the PP2A phosphatase. FEBS Lett 582(8), 1182\u20131188 (2008). https:\/\/doi.org\/10.1016\/j.febslet.2007.12.036","journal-title":"FEBS Lett"},{"issue":"4","key":"4116_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s1534-5807(03)00089-3","volume":"4","author":"Y Minoshima","year":"2003","unstructured":"Y. Minoshima, T. Kawashima, K. Hirose, Y. Tonozuka, A. Kawajiri, Y.C. Bao, X. Deng, M. Tatsuka, S. Narumiya, W.S. May Jr, T. Nosaka, K. Semba, T. Inoue, T. Satoh, M. Inagaki, T. Kitamura, Phosphorylation by aurora B converts MgcRacGAP to a RhoGAP during cytokinesis. Dev Cell 4(4), 549\u2013560 (2003). https:\/\/doi.org\/10.1016\/s1534-5807(03)00089-3","journal-title":"Dev Cell"},{"issue":"5","key":"4116_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","volume":"7","author":"S Melmed","year":"2011","unstructured":"S. Melmed, Pathogenesis of pituitary tumors. Nat Rev Endocrinol 7(5), 257\u2013266 (2011). https:\/\/doi.org\/10.1038\/nrendo.2011.40","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"4116_CR42","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/15384101.2018.1442139","volume":"17","author":"J Trouillas","year":"2018","unstructured":"J. Trouillas, G. Raverot, Dysregulation of cell cycle in animal models and human neuroendocrine pituitary tumors (PitNET). Cell Cycle 17(8), 917 (2018). https:\/\/doi.org\/10.1080\/15384101.2018.1442139","journal-title":"Cell Cycle"},{"issue":"4","key":"4116_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1210\/mend.11.4.9911","volume":"11","author":"L Pei","year":"1997","unstructured":"L. Pei, S. Melmed, Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11(4), 433\u2013441 (1997). https:\/\/doi.org\/10.1210\/mend.11.4.9911","journal-title":"Mol Endocrinol"},{"issue":"4","key":"4116_CR44","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1172\/JCI78173","volume":"125","author":"C Zhou","year":"2015","unstructured":"C. Zhou, Y. Jiao, R. Wang, S.G. Ren, K. Wawrowsky, S. Melmed, STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion. J Clin Invest 125(4), 1692\u20131702 (2015). https:\/\/doi.org\/10.1172\/JCI78173","journal-title":"J Clin Invest"},{"issue":"4","key":"4116_CR45","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1053\/j.gastro.2018.07.010","volume":"155","author":"XM Yang","year":"2018","unstructured":"X.M. Yang, X.Y. Cao, P. He, J. Li, M.X. Feng, Y.L. Zhang, X.L. Zhang, Y.H. Wang, Q. Yang, L. Zhu, H.Z. Nie, S.H. Jiang, G.A. Tian, X.X. Zhang, Q. Liu, J. Ji, X. Zhu, Q. Xia, Z.G. Zhang, Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Gastroenterology 155(4), 1233\u20131249 e22 (2018). https:\/\/doi.org\/10.1053\/j.gastro.2018.07.010","journal-title":"Gastroenterology"},{"key":"4116_CR46","doi-asserted-by":"publisher","first-page":"101804","DOI":"10.1016\/j.tice.2022.101804","volume":"76","author":"X Ruan","year":"2022","unstructured":"X. Ruan, J. Jiang, RACGAP1 promotes proliferation and cell cycle progression by regulating CDC25C in cervical cancer cells. Tissue Cell 76, 101804 (2022). https:\/\/doi.org\/10.1016\/j.tice.2022.101804","journal-title":"Tissue Cell"},{"issue":"3","key":"4116_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"M. Malumbres, M. Barbacid, Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9(3), 153\u2013166 (2009). https:\/\/doi.org\/10.1038\/nrc2602","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"4116_CR48","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.tcb.2018.07.002","volume":"28","author":"S Goel","year":"2018","unstructured":"S. Goel, M.J. DeCristo, S.S. McAllister, J.J. Zhao, CDK4\/6 Inhibition in Cancer: Beyond Cell Cycle Arrest. Trends Cell Biol 28(11), 911\u2013925 (2018). https:\/\/doi.org\/10.1016\/j.tcb.2018.07.002","journal-title":"Trends Cell Biol"},{"issue":"9","key":"4116_CR49","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1021\/acs.jmedchem.8b01469","volume":"62","author":"S Tadesse","year":"2019","unstructured":"S. Tadesse, E.C. Caldon, W. Tilley, S. Wang, Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update. J Med Chem 62(9), 4233\u20134251 (2019). https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01469","journal-title":"J Med Chem"},{"issue":"3","key":"4116_CR50","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/j.1460-2075.1992.tb05135.x","volume":"11","author":"M Pagano","year":"1992","unstructured":"M. Pagano, R. Pepperkok, F. Verde, W. Ansorge, G. Draetta, Cyclin A is required at two points in the human cell cycle. EMBO J 11(3), 961\u2013971 (1992). https:\/\/doi.org\/10.1002\/j.1460-2075.1992.tb05135.x","journal-title":"EMBO J"},{"issue":"5","key":"4116_CR51","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3892\/ijmm.2019.4325","volume":"44","author":"N Li","year":"2019","unstructured":"N. Li, L.J. Wang, W.L. Xu, S. Liu, J.Y. Yu, MicroRNA\u2011379\u20115p suppresses renal fibrosis by regulating the LIN28\/let\u20117 axis in diabetic nephropathy. Int J Mol Med 44(5), 1619\u20131628 (2019). https:\/\/doi.org\/10.3892\/ijmm.2019.4325","journal-title":"Int J Mol Med"},{"issue":"2","key":"4116_CR52","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/er.2006-0042","volume":"28","author":"G Vlotides","year":"2007","unstructured":"G. Vlotides, T. Eigler, S. Melmed, Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr Rev 28(2), 165\u2013186 (2007). https:\/\/doi.org\/10.1210\/er.2006-0042","journal-title":"Endocr Rev"},{"issue":"4","key":"4116_CR53","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1080\/21541248.2016.1220350","volume":"9","author":"CD Lawson","year":"2018","unstructured":"C.D. Lawson, C.J. Der, Filling GAPs in our knowledge: ARHGAP11A and RACGAP1 act as oncogenes in basal-like breast cancers. Small GTPases 9(4), 290\u2013296 (2018). https:\/\/doi.org\/10.1080\/21541248.2016.1220350","journal-title":"Small GTPases"},{"issue":"1","key":"4116_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14218\/JCTH.2022.00060","volume":"11","author":"SL Xin","year":"2023","unstructured":"S.L. Xin, X.L. Pan, X.Y. Xu, Y.Y. Yu, USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells. J Clin Transl Hepatol 11(1), 45\u201357 (2023). https:\/\/doi.org\/10.14218\/JCTH.2022.00060","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"4116_CR55","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/path.2561","volume":"218","author":"C Gulmann","year":"2009","unstructured":"C. Gulmann, K.M. Sheehan, R.M. Conroy, J.D. Wulfkuhle, V. Espina, M.J. Mullarkey, E.W. Kay, L.A. Liotta, E.F. Petricoin, Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer. J Pathol 218(4), 514\u2013519 (2009). https:\/\/doi.org\/10.1002\/path.2561","journal-title":"J Pathol"},{"issue":"9","key":"4116_CR56","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00417-010-1607-3","volume":"249","author":"Z Chen","year":"2011","unstructured":"Z. Chen, A. Yang, C. Xu, Y. Xing, W. Gong, J. Li, c-Jun N-terminal kinase is involved in the regulation of proliferation and apoptosis by integrin-linked kinase in human retinoblastoma cells. Graefes Arch Clin Exp Ophthalmol 249(9), 1399\u20131407 (2011). https:\/\/doi.org\/10.1007\/s00417-010-1607-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"4116_CR57","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/modpathol.3800662","volume":"19","author":"K Jorgensen","year":"2006","unstructured":"K. Jorgensen, B. Davidson, V.A. Florenes, Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma. Mod Pathol 19(11), 1446\u20131455 (2006). https:\/\/doi.org\/10.1038\/modpathol.3800662","journal-title":"Mod Pathol"},{"issue":"3","key":"4116_CR58","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.humpath.2009.08.018","volume":"41","author":"X Wang","year":"2010","unstructured":"X. Wang, L. Chao, X. Li, G. Ma, L. Chen, Y. Zang, G. Zhou, Elevated expression of phosphorylated c-Jun NH2-terminal kinase in basal-like and \u201ctriple-negative\u201d breast cancers. Hum Pathol 41(3), 401\u2013406 (2010). https:\/\/doi.org\/10.1016\/j.humpath.2009.08.018","journal-title":"Hum Pathol"},{"issue":"1","key":"4116_CR59","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.humpath.2006.06.027","volume":"38","author":"E \u00d8degaard","year":"2007","unstructured":"E. \u00d8degaard, A.C. Staff, V.M. Abeler, J. Kopolovic, M. Onsrud, P. Lazarovici, B. Davidson, The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma. Hum Pathol 38(1), 140\u2013146 (2007). https:\/\/doi.org\/10.1016\/j.humpath.2006.06.027","journal-title":"Hum Pathol"},{"key":"4116_CR60","doi-asserted-by":"publisher","unstructured":"Zhu, Z., Hu B., Zhu D., Li X., Chen D., Wu N., Rao Q., Zhang Z., Wang H., Zhu Y., Bromocriptine sensitivity in bromocriptine-induced drug-resistant prolactinomas is restored by inhibiting FGF19\/FGFR4\/PRL. J Endocrinol Invest, 2024. https:\/\/doi.org\/10.1007\/s40618-024-02408-0","DOI":"10.1007\/s40618-024-02408-0"},{"issue":"6","key":"4116_CR61","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.3892\/mmr.2014.2078","volume":"9","author":"YY Gong","year":"2014","unstructured":"Y.Y. Gong, Y.Y. Liu, S. Yu, X.N. Zhu, X.P. Cao, H.P. Xiao, Ursolic acid suppresses growth and adrenocorticotrophic hormone secretion in AtT20 cells as a potential agent targeting adrenocorticotrophic hormone-producing pituitary adenoma. Mol Med Rep 9(6), 2533\u20132539 (2014). https:\/\/doi.org\/10.3892\/mmr.2014.2078","journal-title":"Mol Med Rep"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-024-04116-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-024-04116-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T03:56:06Z","timestamp":1742788566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-024-04116-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["4116"],"URL":"https:\/\/doi.org\/10.1007\/s12020-024-04116-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4353892\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics and Research Committees of Huashan Hospital, Fudan University. The tumor sections and corresponding clinical information were obtained with the written consent from all patients. The animal experiments were performed according to the ethical guidelines and approved by the Institute Animal Care and Use Committee (IACUC), Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}